463 results on '"Gooderham, Melinda J."'
Search Results
102. Long-Term Single Center Experience in Treating Plaque Psoriasis With Guselkumab
103. Management of Plaque Psoriasis With Biologic Therapies in Women of Child-Bearing Potential Consensus Paper
104. Inflammatory bowel disease in patients with psoriasis treated with interleukin-17 inhibitors
105. Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis
106. Reasons for the Termination of Interleukin-17 Inhibitor Medications in the Treatment of Plaque Psoriasis: A Real-World Retrospective Study.
107. Efficacy and Safety of Oral Janus Kinase 1 Inhibitor Abrocitinib for Patients With Atopic Dermatitis
108. Could it be gluten? Additional skin conditions associated with celiac disease.
109. Real‐world, long‐term treatment patterns of commonly used biologics in Canadian patients with moderate‐to‐severe chronic plaque psoriasis.
110. Referee report. For: Case Report: Paradoxical acrodermatitis of Hallopeau-like eruption following anti-IL-17 therapy [version 1; peer review: 2 approved]
111. An update on generalized pustular psoriasis
112. A soy protein isolate rich in genistein and daizein and its effects on plasma isoflavone concentrations, platelet aggregation, blood lipids and fatty acid composition of plasma phospholipid in normal men
113. Consistent response to guselkumab treatment between Hispanic and non-Hispanic patients with psoriasis: an analysis from VOYAGE 1 and VOYAGE 2.
114. Considerations for defining and diagnosing generalized pustular psoriasis.
115. Dupilumab: an evidence-based review of its potential in the treatment of atopic dermatitis
116. Hong_article_section_V__803625 – Supplemental material for Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section V: Consensus Statements on the Assessment and Management of Adult Patients With Moderate-to-Severe Atopic Dermatitis
117. 1329_Section_0_Supplementary_Appendix_A_19Jul18 – Supplemental material for Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document
118. Supplemental Material, PROPEL_Manuscript_Supplementary_File_3 – Canadian Patients’ Preferences in Topical Psoriasis Care: Insights From the PROPEL Surveys
119. JCMS_Gooderham_803627 – Supplemental material for Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document
120. JCMS_Dhadwal_805721 – Supplemental material for Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section IV: Treatment Options for the Management of Atopic Dermatitis
121. JCMS_Gooderham_803628 – Supplemental material for Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section II: Tools for Assessing the Severity of Atopic Dermatitis
122. JCMS_Kirchhof_803626 – Supplemental material for Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section I: Pathophysiology of Atopic Dermatitis and Implications for Systemic Therapy
123. 1329_Section_V_Supplementary_Table_1 – Supplemental material for Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section V: Consensus Statements on the Assessment and Management of Adult Patients With Moderate-to-Severe Atopic Dermatitis
124. JCMS_Hong_805709 – Supplemental material for Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section III: Evaluation of Atopic Dermatitis Patients for Comorbidities
125. Consistent response to guselkumab treatment between Hispanic and non-Hispanic patients with psoriasis: an analysis from VOYAGE 1 and VOYAGE 2
126. An update on generalized pustular psoriasis
127. The Use of Biologic Therapy in the Treatment of Acrodermatitis Continua of Hallopeau: A Review
128. Canadian Research Contributions per Medical Specialty in 2 High-Impact Journals
129. The Use of Janus Kinase Inhibitors in Alopecia Areata: A Review of the Literature
130. Acrodermatitis continua of Hallopeau successfully treated with adalimumab: A case report
131. Healthcare Providers Face Numerous Challenges in Treating Patients with Psoriasis: Results from a Mixed-Methods Study
132. Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document
133. Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section I: Pathophysiology of Atopic Dermatitis and Implications for Systemic Therapy
134. Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section IV: Treatment Options for the Management of Atopic Dermatitis
135. Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section III: Evaluation of Atopic Dermatitis Patients for Comorbidities
136. Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section V: Consensus Statements on the Assessment and Management of Adult Patients With Moderate-to-Severe Atopic Dermatitis
137. TYK2 inhibition: changing the treatment landscape for psoriasis?
138. Eight-Patient Case Series of Palmoplantar Pustulosis Treated Successfully With Apremilast
139. Canadian Patients’ Preferences in Topical Psoriasis Care: Insights From the PROPEL Surveys
140. An Update on the Use of Alitretinoin for Chronic Hand Dermatitis in a Dermatology Practice Setting
141. Hidradenitis suppurativa with SAPHO syndrome maintained effectively with adalimumab, methotrexate, and intralesional corticosteroid injections
142. A Guide to Topical Vehicle Formulations
143. 423 Long-term efficacy of abrocitinib up to 96 weeks in adults with moderate-to-severe atopic dermatitis stratified by age: a post hoc analysis of the JADE EXTEND phase 3 trial.
144. Persistency of Biologic Therapies for Plaque Psoriasis in 2 Large Community Practices
145. Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice
146. Atopic Dermatitis, Depression, and Suicidality
147. Review of Atopic Dermatitis and Topical Therapies
148. Real-World Experience With Apremilast in Treating Psoriasis
149. A Guide to Topical Vehicle Formulations.
150. Persistency of Biologic Therapies for Plaque Psoriasis in 2 Large Community Practices.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.